Cancel anytime
Quantum BioPharma Ltd. (QNTM)QNTM
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: QNTM (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -52.06% | Upturn Advisory Performance 1 | Avg. Invested days: 18 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -52.06% | Avg. Invested days: 18 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.17M USD |
Price to earnings Ratio - | 1Y Target Price 169 |
Dividends yield (FY) - | Basic EPS (TTM) -13 |
Volume (30-day avg) 985401 | Beta 0.85 |
52 Weeks Range 3.50 - 97.50 | Updated Date 09/15/2024 |
Company Size Small-Cap Stock | Market Capitalization 6.17M USD | Price to earnings Ratio - | 1Y Target Price 169 |
Dividends yield (FY) - | Basic EPS (TTM) -13 | Volume (30-day avg) 985401 | Beta 0.85 |
52 Weeks Range 3.50 - 97.50 | Updated Date 09/15/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -36.12% | Return on Equity (TTM) -63.89% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 3468299 | Price to Sales(TTM) 91.86 |
Enterprise Value to Revenue 98.56 | Enterprise Value to EBITDA -1.57 |
Shares Outstanding 1548890 | Shares Floating 978586 |
Percent Insiders 14.14 | Percent Institutions 1.54 |
Trailing PE - | Forward PE - | Enterprise Value 3468299 | Price to Sales(TTM) 91.86 |
Enterprise Value to Revenue 98.56 | Enterprise Value to EBITDA -1.57 | Shares Outstanding 1548890 | Shares Floating 978586 |
Percent Insiders 14.14 | Percent Institutions 1.54 |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
QNTM: A Comprehensive Overview
Company Profile:
Detailed History and Background:
Founded in 2015, QNTM (formerly QuantumScape) is a research and development company focused on creating next-generation solid-state lithium-metal batteries for electric vehicles (EVs). Building on the research of Stanford University professor Fritz Prinz, QNTM aims to address the limitations of conventional lithium-ion batteries, including slow charging times, limited range, and safety concerns.
Core Business Areas:
- Solid-State Battery Technology: QNTM's primary focus is developing and commercializing solid-state batteries, which offer higher energy density, faster charging, and improved safety compared to traditional lithium-ion batteries.
- Materials Science: The company leverages its expertise in materials science to create innovative battery components, including a solid-state electrolyte and a lithium-metal anode.
- Battery Cell and Pack Design: QNTM designs and develops battery cells and packs tailored for the specific needs of electric vehicles.
Leadership Team and Corporate Structure:
- Jagdeep Singh: Founder and CEO of QNTM, with extensive experience in materials science and entrepreneurship.
- Fritz Prinz: Co-founder and Chief Scientist, a renowned Stanford University professor with expertise in battery technology.
- Keith Wandell: Chief Operating Officer, with a strong background in manufacturing and operations.
- Tim Holme: Chief Financial Officer, bringing extensive experience in finance and accounting.
Top Products and Market Share:
Products and Offerings:
- Solid-State Battery Cells: QNTM is currently developing single-layer and multi-layer solid-state battery cells with high energy density and fast charging capabilities.
- Solid-State Battery Packs: The company is designing and developing battery packs for electric vehicles, targeting a range of 300 miles or more on a single charge.
Market Share:
As QNTM is still in the research and development phase, it does not currently have a market share. However, the company is aiming to become a leading supplier of solid-state batteries for the electric vehicle industry, which is estimated to reach a market size of $30 billion by 2030.
Competition:
QNTM faces competition from other solid-state battery developers, such as:
- Solid Power (SLDP): A US-based company focused on developing sulfide-based solid-state batteries.
- Ionic Materials (IMR): A US-based company developing polymer-based solid-state batteries.
- Toyota Motor Corp (TM): A Japanese automotive giant investing heavily in solid-state battery development.
Total Addressable Market:
The total addressable market for QNTM is the global electric vehicle battery market. This market is expected to reach a size of $30 billion by 2030, driven by increasing EV adoption and the need for improved battery performance.
Financial Performance:
Recent Financial Statements:
As QNTM is still in the research and development phase, it has not yet generated any significant revenue or earnings. The company is currently focused on investing in R&D and developing its solid-state battery technology.
Financial Health:
QNTM has raised significant funding from investors, including Volkswagen Group and Koch Industries. The company has a strong financial position and is well-funded to continue its development efforts.
Dividends and Shareholder Returns:
QNTM is not currently paying dividends as it is focused on investing in growth. Shareholder returns have been primarily driven by stock price appreciation.
Growth Trajectory:
Historical Growth:
QNTM has shown significant progress in developing its solid-state battery technology. The company has achieved key milestones, including demonstrating full single-layer cell functionality and developing a multi-layer cell prototype.
Future Growth:
QNTM is targeting commercialization of its solid-state battery technology by 2025. The company is expected to experience significant revenue growth as it begins supplying batteries to electric vehicle manufacturers.
Market Dynamics:
Industry Trends:
The electric vehicle industry is experiencing rapid growth, driven by technological advancements, government incentives, and increasing environmental concerns. Solid-state batteries are expected to play a crucial role in this growth due to their superior performance characteristics.
Demand-Supply Scenario:
The demand for electric vehicle batteries is expected to outpace supply in the coming years, creating significant opportunities for companies like QNTM.
Technological Advancements:
QNTM is at the forefront of solid-state battery technology development. The company is constantly innovating and improving its technology to meet the needs of the electric vehicle industry.
Market Positioning:
QNTM is well-positioned to capitalize on the growing demand for solid-state batteries. The company has a strong intellectual property portfolio, a talented team, and significant financial backing.
Competitors:
QNTM faces stiff competition from other solid-state battery developers, but the company believes its superior technology and strategic partnerships give it a competitive edge.
Potential Challenges and Opportunities:
Key Challenges:
- Successfully scaling up production of solid-state batteries to meet demand.
- Demonstrating the long-term reliability and durability of its battery technology.
- Maintaining its technological leadership in a rapidly evolving industry.
Potential Opportunities:
- Partnering with major electric vehicle manufacturers to supply batteries.
- Expanding into new markets, such as stationary energy storage and consumer electronics.
- Developing next-generation battery technologies beyond solid-state.
Recent Acquisitions (last 3 years):
QNTM has not made any significant acquisitions in the last 3 years. The company has focused on internal research and development efforts.
AI-Based Fundamental Rating:
Rating: 8/10
Justification:
QNTM has strong fundamentals, including a proprietary solid-state battery technology, a talented team, and significant financial backing. The company is well-positioned to capitalize on the growing demand for electric vehicle batteries. However, the company is still in the early stages of development, and there are risks associated with commercializing its technology.
Sources and Disclaimers:
Disclaimer: This information is intended for general knowledge and educational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making any investment decisions.
Sources:
- QNTM website: https://www.quantumscape.com/
- SEC filings: https://www.sec.gov/edgar/search/
- Market research reports: https://www.grandviewresearch.com/
- Industry publications: https://www.greencarreports.com/
- News articles: https://www.reuters.com/
Please note that this overview is based on information available as of November 2023. It is important to stay updated on the latest developments and news regarding QNTM and the solid-state battery industry before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Quantum BioPharma Ltd.
Exchange | NASDAQ | Headquaters | Toronto, ON, Canada |
IPO Launch date | 2018-06-08 | Founder, CEO, President & Executive Co-Chairman | Mr. Zeeshan Saeed |
Sector | Healthcare | Website | https://www.fsdpharma.com |
Industry | Drug Manufacturers - Specialty & Generic | Full time employees | - |
Headquaters | Toronto, ON, Canada | ||
Founder, CEO, President & Executive Co-Chairman | Mr. Zeeshan Saeed | ||
Website | https://www.fsdpharma.com | ||
Website | https://www.fsdpharma.com | ||
Full time employees | - |
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.